http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleInterno/MATRICOLA8153
CHIARA LAEZZA
- Type
- Label
- CHIARA LAEZZA (literal)
- CHIARA LAEZZA (literal)
- Subject
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Statins in neurological disorders: An overview and update (Articolo in rivista) (Prodotto della ricerca)
- Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation (Articolo in rivista) (Prodotto della ricerca)
- N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice (Articolo in rivista) (Prodotto della ricerca)
- Update on the endocannabinoid system as an anticancer target. (Articolo in rivista) (Prodotto della ricerca)
- Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer. (Articolo in rivista) (Prodotto della ricerca)
- Endocannabinoids as emergine suppressors of angiogenesis and tumor invasion (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A new strategy to block tumor growth by inhibiting endocannabinoid inactivation (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway (Articolo in rivista) (Prodotto della ricerca)
- Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis (Articolo in rivista) (Prodotto della ricerca)
- N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Anandamide inhibits the Wnt/?-catenin signalling pathway in human breast cancer MDA MB 231 cells. (Articolo in rivista) (Prodotto della ricerca)
- Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. (Articolo in rivista) (Prodotto della ricerca)
- Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. (Articolo in rivista) (Prodotto della ricerca)
- Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cannabinoid receptor CB1 antagonists state of the art and challenges. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A new role of anandamide in human sperm: focus on metabolism. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Involvement of Akt/NF-ºB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. (Articolo in rivista) (Prodotto della ricerca)
- The endocannabinoid signaling system in cancer. (Articolo in rivista) (Prodotto della ricerca)
- The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. (Articolo in rivista) (Prodotto della ricerca)
- Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. (Articolo in rivista) (Prodotto della ricerca)
- Endocannabinoids in endocrine and related tumours. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Inhibitory effects of cannabinoid CB 1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration. (Articolo in rivista) (Prodotto della ricerca)
- Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis (Articolo in rivista) (Prodotto della ricerca)
- From anecdotal evidences of cannabinoids in multiple sclerosis to emerging new therapeutical approaches. (Articolo in rivista) (Prodotto della ricerca)
- Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. (Articolo in rivista) (Prodotto della ricerca)
- Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. (Articolo in rivista) (Prodotto della ricerca)
- Antiangiogenetic activity of the endocannabinoid anandamide.Correlation to its tumour-suppressor efficacy (Articolo in rivista) (Prodotto della ricerca)
- Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold. (Articolo in rivista) (Prodotto della ricerca)
- PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines. (Articolo in rivista) (Prodotto della ricerca)
- Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. (Articolo in rivista) (Prodotto della ricerca)
- Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Anandamide inhibits adhesion and migration of breast cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Cannabinoids and cancer: pros and cons of an antitumour strategy. (Articolo in rivista) (Prodotto della ricerca)
- Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Anandamide inhibits the Wnt/?-catenin signalling pathway in human breast cancer MDA MB 231 cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Astersedifolioside A-C, three new oleane-type saponins with antiproliferative activity (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site. (Articolo in rivista) (Prodotto della ricerca)
- Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. (Articolo in rivista) (Prodotto della ricerca)
- Reply to the letter to the editor (Articolo in rivista) (Prodotto della ricerca)
- Human Sperm Anatomy: Ultrastructural Localization of the Cannabinoid1 Receptor and a Potential Role of Anandamide in Sperm Survival and Acrosome Reaction. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. (Articolo in rivista) (Prodotto della ricerca)
- N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. (Articolo in rivista) (Prodotto della ricerca)
- Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. (Articolo in rivista) (Prodotto della ricerca)
- Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation. (Articolo in rivista) (Prodotto della ricerca)
- Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- 1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Coautore
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
Incoming links:
- Coautore
- Ha pubblicazioni con
- Partecipazione di
- Ha afferente
- Rapporto con persona
- Autore CNR
- Anandamide inhibits adhesion and migration of breast cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Cannabinoids and cancer: pros and cons of an antitumour strategy. (Articolo in rivista) (Prodotto della ricerca)
- The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site. (Articolo in rivista) (Prodotto della ricerca)
- Endocannabinoids in endocrine and related tumours. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Inhibitory effects of cannabinoid CB 1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation. (Articolo in rivista) (Prodotto della ricerca)
- Update on the endocannabinoid system as an anticancer target. (Articolo in rivista) (Prodotto della ricerca)
- Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer. (Articolo in rivista) (Prodotto della ricerca)
- The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. (Articolo in rivista) (Prodotto della ricerca)
- Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. (Articolo in rivista) (Prodotto della ricerca)
- Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. (Articolo in rivista) (Prodotto della ricerca)
- Cannabinoid receptor CB1 antagonists state of the art and challenges. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A new role of anandamide in human sperm: focus on metabolism. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Involvement of Akt/NF-ºB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. (Articolo in rivista) (Prodotto della ricerca)
- Astersedifolioside A-C, three new oleane-type saponins with antiproliferative activity (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation (Articolo in rivista) (Prodotto della ricerca)
- HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway (Articolo in rivista) (Prodotto della ricerca)
- Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. (Articolo in rivista) (Prodotto della ricerca)
- Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. (Articolo in rivista) (Prodotto della ricerca)
- Reply to the letter to the editor (Articolo in rivista) (Prodotto della ricerca)
- Human Sperm Anatomy: Ultrastructural Localization of the Cannabinoid1 Receptor and a Potential Role of Anandamide in Sperm Survival and Acrosome Reaction. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. (Articolo in rivista) (Prodotto della ricerca)
- N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. (Articolo in rivista) (Prodotto della ricerca)
- Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. (Articolo in rivista) (Prodotto della ricerca)
- Endocannabinoids as emergine suppressors of angiogenesis and tumor invasion (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis (Articolo in rivista) (Prodotto della ricerca)
- Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A new strategy to block tumor growth by inhibiting endocannabinoid inactivation (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. (Articolo in rivista) (Prodotto della ricerca)
- Antiangiogenetic activity of the endocannabinoid anandamide.Correlation to its tumour-suppressor efficacy (Articolo in rivista) (Prodotto della ricerca)
- From anecdotal evidences of cannabinoids in multiple sclerosis to emerging new therapeutical approaches. (Articolo in rivista) (Prodotto della ricerca)
- Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis (Articolo in rivista) (Prodotto della ricerca)
- Anandamide inhibits the Wnt/?-catenin signalling pathway in human breast cancer MDA MB 231 cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold. (Articolo in rivista) (Prodotto della ricerca)
- Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Anandamide inhibits the Wnt/?-catenin signalling pathway in human breast cancer MDA MB 231 cells. (Articolo in rivista) (Prodotto della ricerca)
- 1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The endocannabinoid signaling system in cancer. (Articolo in rivista) (Prodotto della ricerca)
- N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. (Articolo in rivista) (Prodotto della ricerca)
- Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. (Articolo in rivista) (Prodotto della ricerca)
- PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines. (Articolo in rivista) (Prodotto della ricerca)
- N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice (Articolo in rivista) (Prodotto della ricerca)
- Statins in neurological disorders: An overview and update (Articolo in rivista) (Prodotto della ricerca)
- Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration. (Articolo in rivista) (Prodotto della ricerca)
- Http://www.w3.org/2004/02/skos/core#isSubjectOf